
Are You PrEP’ed for Lenacapavir?
Published on January 23, 2026

Australia's TGA has approved lenacapavir, a groundbreaking twice-yearly injectable HIV PrEP medication. Learn how this new capsid inhibitor could transform HIV prevention, who it benefits, and what needs to happen for affordable PBS access.
